Thoughts, page-3

Michael Ratigan, Senior Vice President and Chief Commercial Officer , joined Unilife in 2011 from Becton Dickinson where he was a global commercial leader for Self-Injection Systems and also led commercial efforts for Pre-Filled Syringes in the North American market. Since joining Unilife Mr. Ratigan has led Unilife’s commercial efforts, including the entry into multiple strategic collaborations with leading pharmaceutical and biopharmaceutical companies
Ian Hanson, Senior Vice President and General Manager of Unilife’s
Wearable Injector and Auto Injector business unit, joined Unilife in 2011 from Medtronic Diabetes, where he held senior leadership roles in the development and commercialization of insulin delivery devices and diabetes management systems. At Unilife, Mr. Hanson initiated and led the development of Unilife’s industry-leading wearable injector platform and team.

UNIS now has 2 distinct divisions, headed by UNIS management from major leaders in their fields.
UNIS has no known declared approved FDA approvals or even submission for approval and based on previous experience not enough cash for 6 months.

It would be easy for some to envisage Syringes Division ending up with BD or similar and Wearables Division with Medimunne or similar , and that would offer one explanation to explain the competition appearing to be sitting on their hands.

That would also eliminate the one big obstacle preventing UNIS success and that is the Aussie ownership.

The Board would be we advised to seek overseas partnership / ownership- like China- someone with money, that is not connected with Wall St
All IMO
Read up on Pacific Dunlop and Tones Spices to understand Australian companies trying to establish in USA
There is no suggestion of wrongdoing by any person mention in this post